# Atelerix Life Sciences Inc.

Canonical: https://abierto.us/vendors/atelerix-life-sciences-inc-td8nl4uwnvw8

- UEI: TD8NL4UWNVW8
- CAGE: 8ZNE9
- Location: Charlottesville, VA
- Awards in window: 1 (1 transactions), -$680,885 obligated, July 23, 2024 to July 23, 2024

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, -$680,885

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): -$680,885

## Competition

- Competed Under SAP: 1 awards

## Largest awards

- 75A50123C00053 (definitive contract): -$680,885, Barda - Aspr / Daappo / Barda DCMA. Atelerix - the Overall Objective of This Contract Is to Plan and Execute a Phase 1A Clinical Trial (Hereafter Referred to as the ?phase 1A Trial?) of the Novel Small Molecule Atlx-0199 in 30 Normal Healthy Subjects. the Goal of the Clinical Trial Is. https://www.usaspending.gov/award/CONT_AWD_75A50123C00053_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/atelerix-life-sciences-inc-td8nl4uwnvw8.